Why is Bliss GVS Pharma falling/rising?

As of 12-Sep, Bliss GVS Pharma Ltd's stock price is currently at 152.45, reflecting a decline of 1.85, or 1.2%. The stock has underperformed its sector today by 1.49%, and its delivery volume has decreased by 6.23% compared to the 5-day average, indicating falling investor participation. Over the past week, the stock has dropped by 2.28%, and it has also seen a significant decline of 12.71% over the past month. Despite a strong performance in the long term with a 20.13% return over the past year, the company's profits have decreased by 3.6%, and it is trading at a premium compared to its peers, which may be contributing to the recent downward pressure on the stock.
In the broader market context, the Sensex has increased by 1.48% over the past week, contrasting with Bliss GVS Pharma's decline, which highlights the stock's underperformance relative to the benchmark. While the company has shown strong returns over the long term, its recent performance has not kept pace with the market, as evidenced by its negative returns over the past month and week. This divergence suggests that investor sentiment may be shifting, particularly given the company's flat ROE and average debt-to-equity ratio, which could be causing caution among investors in the short term.